ONTX Onconova Therapeutics, Inc. Stock Quote

ONTX [NASD]

Index	-	P/E	-	EPS (ttm)	-2.02	Insider Own	0.30%	Shs Outstand	236.61M	Perf Week	-0.76%
Market Cap	82.94M	Forward P/E	-	EPS next Y	-1.15	Insider Trans	177.30%	Shs Float	221.88M	Perf Month	-23.22%
Income	-24.80M	PEG	-	EPS next Q	-0.28	Inst Own	23.10%	Short Float	0.36%	Perf Quarter	-47.81%
Sales	0.20M	P/S	414.68	EPS this Y	90.30%	Inst Trans	0.08%	Short Ratio	0.64	Perf Half Y	-49.04%
Book/sh	2.54	P/B	2.04	EPS next Y	-71.40%	ROA	-81.10%	Target Price	3.05	Perf Year	-69.91%
Cash/sh	3.00	P/C	1.73	EPS next 5Y	-	ROE	-139.30%	52W Range	2.85 - 28.95	Perf YTD	-25.72%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-403.20%	52W High	-82.07%	Beta	1.74
Dividend %	-	Quick Ratio	6.60	Sales past 5Y	-54.20%	Gross Margin	-	52W Low	82.01%	ATR	0.37
Employees	11	Current Ratio	6.60	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	40.01	Volatility	6.25% 7.02%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	32.30%	Profit Margin	-	Rel Volume	0.18	Prev Close	4.97
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 17 AMC	Payout	-	Avg Volume	1.23M	Price	5.19
Recom	2.20	SMA20	-6.68%	SMA50	-20.82%	SMA200	-44.42%	Volume	221,516	Change	4.43%

May-18-21

Initiated

Guggenheim

Buy

Mar-01-18

Reiterated

H.C. Wainwright

Buy

$6 → $7.50

Jan-17-18

Downgrade

Maxim Group

Buy → Hold

Oct-09-17

Initiated

H.C. Wainwright

Buy

Apr-27-17

Initiated

Laidlaw

Buy

$10

Jul-01-15

Upgrade

Piper Jaffray

Neutral → Overweight

May-05-15

Initiated

H.C. Wainwright

Buy

Jun-28-21 08:00AM	Onconova Therapeutics Provides an Update on the Phase 1/2a Trial of Rigosertib-Nivolumab Combination in KRAS+ Non-Small Cell Lung Cancer GlobeNewswire
Jun-22-21 08:00AM	Onconova Therapeutics Regains Compliance with Nasdaq Continued Listing Requirement GlobeNewswire
Jun-17-21 08:00AM	Onconova Therapeutics Announces the Peer-Reviewed Publication of Preclinical Data Demonstrating the Synergistic Anti-Cancer Activity of Rigosertib Combined with Immune Checkpoint Blockade GlobeNewswire
Jun-10-21 08:00AM	Onconova Therapeutics Announces Participation in A.G.P.s Upcoming Virtual Summer Healthcare Symposium GlobeNewswire
Jun-04-21 12:00PM	Onconova Therapeutics, Inc. (ONTX) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Jun-03-21 08:00AM	Onconova Therapeutics Announces Upcoming Presentation at 2021 BIO Digital GlobeNewswire -6.13%
Jun-01-21 08:00AM	Onconova Therapeutics Announces the Appointment of Mark Gelder, M.D., as Chief Medical Officer GlobeNewswire
May-21-21 08:00AM	Onconova Therapeutics Announces the Initial Dosing of the First Patient in the U.S. Phase 1 Clinical Trial of ON 123300 GlobeNewswire -15.71%
May-20-21 08:32AM	Onconova Therapeutics Announces Reverse Stock Split and Decrease in Authorized Shares GlobeNewswire -21.08%
May-17-21 04:05PM	Onconova Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update GlobeNewswire +17.30%
02:45PM	Onconova Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
May-14-21 10:25AM	7 Reddit Penny Stocks Promising to Cure Cancer InvestorPlace
May-10-21 08:00AM	Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2021 Financial Results on May 17, 2021 GlobeNewswire -8.37%
May-06-21 03:01PM	Onconova Therapeutics, Inc. (ONTX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-22-21 08:00AM	Onconova Announces First Patient Dosed in Investigator-Initiated Phase 2 Study of Rigosertib in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma GlobeNewswire +21.63%
Apr-01-21 08:00AM	Onconova Therapeutics Announces Enrollment in Second Cohort of Phase 1 Study with ON 123300 in China GlobeNewswire -5.01%
Mar-29-21 08:00AM	Onconova to Present at the Spring 2021 Oncology Investor Conference GlobeNewswire -5.11%
Mar-11-21 04:05PM	Onconova Therapeutics Reports Full Year 2020 Financial Results, Provides Business Update GlobeNewswire
02:30PM	Onconova Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Mar-04-21 04:15PM	Onconova Therapeutics to Provide Corporate Update and Full Year 2020 Financial Results GlobeNewswire -18.53%
Mar-01-21 08:00AM	Onconova Therapeutics to Participate in Three Investment Conferences During the Month of March GlobeNewswire
Feb-24-21 08:00AM	Onconova Therapeutics Regains Compliance with Nasdaq Continued Listing Requirement GlobeNewswire
Feb-22-21 09:47AM	5 Value Stocks In The Healthcare Sector Benzinga
Feb-17-21 05:51PM	Why Onconova Therapeutics Stock Soared Today Motley Fool +23.77%
Feb-16-21 04:03PM	Onconova Therapeutics, Inc. Announces Closing of $28.75 Million Public Offering of Common Stock Including Full Exercise of the Over-Allotment Option GlobeNewswire +5.17%
08:00AM	Onconova Therapeutics to Present Corporate Update at the 2021 BIO CEO & Investor Digital Conference GlobeNewswire
Feb-10-21 10:49PM	Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock GlobeNewswire
04:01PM	Onconova Therapeutics, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
Feb-04-21 11:54AM	Return On Capital Employed Overview: Onconova Therapeutics Benzinga +10.12%
Jan-25-21 09:49AM	5 Value Stocks In The Healthcare Sector Benzinga
Jan-14-21 08:00AM	Onconova Therapeutics, Inc. to Present at NobleCon17 Virtual Event GlobeNewswire +5.26%
Jan-07-21 09:40AM	Onconova Therapeutics, Inc. Announces $8.7 Million Public Offering GlobeNewswire
Dec-21-20 08:00AM	Onconova Therapeutics Announces FDA Permission for Study to Proceed Under its Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300 GlobeNewswire
Dec-01-20 10:27AM	Return On Capital Employed Overview: Onconova Therapeutics Benzinga +28.45%
Nov-23-20 08:00AM	Onconova Therapeutics Files Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300 GlobeNewswire
Nov-12-20 04:05PM	Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire +7.99%
02:30PM	Onconova Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Nov-05-20 08:00AM	Onconova Therapeutics to Provide Corporate Update and Third Quarter 2020 Financial Results on November 12, 2020 GlobeNewswire
Oct-13-20 08:00AM	Onconova Therapeutics to Present Update During the 2020 BIO Investor Forum Digital Event GlobeNewswire +24.46%
Oct-05-20 09:44AM	5 Value Stocks To Watch In The Healthcare Sector Benzinga
Sep-21-20 10:08AM	Looking Into Onconova Therapeutics's Return On Capital Employed Benzinga +13.08%
08:00AM	Onconova Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ON 123300 in China by Partner HanX Biopharmaceuticals GlobeNewswire
Sep-09-20 08:00AM	Onconova Therapeutics Announces Participation at Upcoming Virtual Events GlobeNewswire +5.01%
Aug-31-20 08:41AM	Overview Of Value Stocks In The Healthcare Sector Benzinga -12.09%
08:00AM	Onconova Therapeutics Announces Election of James J. Marino, JD, MBA as Chairman of the Board of Directors GlobeNewswire
Aug-26-20 06:42PM	After an Unfortunate Surprise, Can Onconova Bounce Back? Analyst Weighs In TipRanks
Aug-25-20 10:06AM	Onconova's Cancer Study Fails to Meet Endpoint, Shares Down Zacks -15.11%
Aug-24-20 11:15AM	Return On Capital Employed Overview: Onconova Therapeutics Benzinga -66.05%
07:30AM	Onconova Therapeutics Announces Topline Results from the Pivotal Phase 3 INSPIRE Trial GlobeNewswire
Aug-17-20 11:46AM	5 Value Stocks To Watch In The Healthcare Sector Benzinga +8.99%
Aug-12-20 04:37PM	Onconova Therapeutics: Q2 Earnings Insights Benzinga
04:05PM	Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results GlobeNewswire
Aug-07-20 08:00AM	Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020 GlobeNewswire +7.04%
Aug-04-20 08:00AM	Onconova Therapeutics Announces Compliance with Nasdaq Bid Price Requirement GlobeNewswire
Aug-03-20 11:52AM	Onconova (ONTX) to Report Q2 Earnings: What's in the Offing? Zacks
Jul-29-20 01:30PM	Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis GlobeNewswire +13.27%
Jul-27-20 08:00AM	Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease GlobeNewswire +11.71%
Jul-23-20 08:00AM	Onconova Therapeutics Announces Publication of Preclinical Data Supporting Rigosertibs Mechanism of Action as a Targeted Anticancer Therapy GlobeNewswire
Jul-07-20 08:00AM	Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS GlobeNewswire
Jun-23-20 10:43AM	Onconova Initiates Phase I/IIa Study on Lung Cancer Candidate Zacks
08:00AM	Onconova Therapeutics Announces Participation in Noble Capital Markets Investor Webinar GlobeNewswire
Jun-22-20 08:00AM	Onconova Therapeutics Announces the Initiation of a Phase 1/2a Study of Rigosertib plus Nivolumab for the Treatment of KRAS+ Lung Adenocarcinoma GlobeNewswire +6.26%
Jun-12-20 08:00AM	Onconova Therapeutics Announces Presentation at the 25th Congress of the European Hematology Association (EHA) GlobeNewswire
Jun-08-20 08:00AM	Onconova Therapeutics Announces Presentation at BIO Digital 2020 GlobeNewswire
May-28-20 09:44AM	3 Strong Buy Penny Stocks That Offer Massive Potential Gains TipRanks
May-18-20 11:33AM	Edited Transcript of ONTX earnings conference call or presentation 14-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-14-20 04:05PM	Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results GlobeNewswire
May-11-20 08:00AM	Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders GlobeNewswire +8.28%
May-07-20 08:00AM	Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020 GlobeNewswire
Apr-27-20 08:00AM	Onconova Therapeutics Strengthens Board of Directors with Nomination of Life Sciences Industry Veteran GlobeNewswire
Apr-07-20 06:40AM	How 3 Philly-area biopharmaceutical firms are working through coronavirus challenges American City Business Journals
Apr-02-20 07:00AM	Edited Transcript of ONTX earnings conference call or presentation 24-Mar-20 8:30pm GMT Thomson Reuters StreetEvents
Mar-24-20 04:05PM	Onconova Therapeutics Announces Completion of Enrollment of Phase 3 INSPIRE Trial, Provides a Corporate Update, and Reports 2019 Financial Results GlobeNewswire +15.58%
Mar-18-20 08:00AM	Onconova Therapeutics to Provide Corporate Update and Full Year 2019 Financial Results GlobeNewswire
Mar-13-20 09:46AM	Will Onconova Therapeutics Continue to Surge Higher? Zacks
Mar-02-20 09:54AM	Onconova (ONTX) to Report Q4 Earnings: What's in Store? Zacks +6.33%
Feb-21-20 10:12AM	The Zacks Analyst Blog Highlights: Onconova Therapeutics, Abeona Therapeutics, Proteostasis Therapeutics, Applied Therapeutics and Ennis Zacks
Feb-20-20 08:45AM	Onconova Therapeutics, Inc. (ONTX) Shares March Higher, Can It Continue? Zacks
07:03AM	US Dollar Flexes Muscles Against Other Currencies: 5 Winners Zacks
Feb-19-20 11:19AM	The Zacks Analyst Blog Highlights: Apple, Eagle Bancorp Montana, Onconova Therapeutics, Proteostasis Therapeutics and Abeona Therapeutics Zacks +8.06%
Feb-18-20 10:06AM	Coronavirus to Hit Apple Sales: Invest in Domestic Producers Zacks -6.60%
08:00AM	Onconova Therapeutics Announces Participation in Two Upcoming International Conferences GlobeNewswire
Feb-10-20 08:00AM	Onconova Therapeutics to Present Update at Noble Capital Markets Sixteenth Annual Investor Conference in Hollywood, FL GlobeNewswire +22.45%
Feb-04-20 08:00AM	Onconova Therapeutics to Present Update at the 2020 BIO CEO & Investor Conference in New York City GlobeNewswire +19.02%
Jan-23-20 05:44PM	Onconova shares rise after company regains rights to drug in China American City Business Journals +9.12%
08:30AM	Onconova Therapeutics Regains Rigosertib Rights in Greater China GlobeNewswire
Jan-03-20 01:27PM	Onconova Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market GlobeNewswire +16.74%
Jan-02-20 01:48PM	Bucks County biopharm firm plans $10M stock sale American City Business Journals +8.85%
Dec-31-19 11:30AM	Onconova Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-The-Market GlobeNewswire -20.08%
Dec-23-19 07:33PM	Onconova Therapeutics, Inc. (ONTX) Is Burning These Hedge Funds Insider Monkey
Dec-19-19 01:44PM	Onconova Therapeutics, Inc. Announces Closing Of $5.0 Million Registered Direct Offering Priced At-The-Market GlobeNewswire
Dec-18-19 09:05AM	Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire -8.34%
09:00AM	Onconova Therapeutics Announces Exclusive License Agreement with Specialised Therapeutics for Rigosertib in Australia and New Zealand GlobeNewswire
Dec-17-19 07:30AM	Onconova Therapeutics and Pint Pharma Announce Brazilian Health Authority Approval for Initiating INSPIRE Trial with Intravenous Rigosertib in Higher-Risk Myelodysplastic Syndromes in Brazil GlobeNewswire
Dec-10-19 03:07PM	Onconova Therapeutics, Inc. Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire
Dec-09-19 09:00AM	Onconova Therapeutics Announces Data on Genomic Profiles of Higher Risk Myelodysplastic Syndromes Patients Refractory to Azacitidine Therapy Enrolled into the Pivotal INSPIRE Trial and Updated Oral Rigosertib Data Informing a Potential Adaptive Clinical Trial Design at the American Society of Hematology 2019 Annual Meeting GlobeNewswire
08:00AM	Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire
Dec-07-19 08:35AM	The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling Benzinga
Dec-06-19 08:49AM	Benzinga Pro's Top 5 Stocks To Watch For Fri., Dec. 6, 2019: TSLA, ONTX, XHB, BIG, SFIX Benzinga +19.82%
07:30AM	Inceptua Medicines Access and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US GlobeNewswire

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Its novel proprietary multi-kinase inhibitor ON 123300 to target CDK4/6 and other tyrosine kinases. The company's product candidate oral rigosertib, which is in Phase 1 study of rigosertib in combination with a PD-1 inhibitor for patients with progressive K-Ras mutated non-small cell lung cancer; and in Phase 1b/2 for recessive dystrophic epidermolysis bullosa. In addition, it is involved in preclinical work investigating rigosertib in COVID-19. The company has a license agreement with SymBio Pharmaceuticals Limited; and license, development, and commercialization agreement with Pint International SA. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
OLER ABRAHAM N.	SVP Corp Dev & Gen Counsel	Feb 16	Buy	1.00	12,000	12,000	152,000	Feb 17 08:57 AM
Guerin Mark Patrick	Chief Financial Officer	Feb 16	Buy	1.00	15,000	15,000	145,213	Feb 17 08:55 AM
Fruchtman Steven M	President, Chief Executive Off	Feb 16	Buy	1.00	20,000	20,000	236,226	Feb 17 08:48 AM
MARINO JAMES J	Director	Feb 16	Buy	1.00	25,000	25,000	230,716	Feb 17 08:46 AM
Shoemaker Mary Teresa	Director	Feb 16	Buy	1.00	13,000	13,000	50,735	Feb 17 08:45 AM
OLER ABRAHAM N.	SVP Corp Dev & Gen Counsel	Dec 11	Buy	0.32	30,000	9,600	140,000	Dec 14 09:00 AM
Guerin Mark Patrick	Chief Financial Officer	Nov 27	Buy	0.26	4,614	1,200	130,213	Nov 30 05:11 PM
Shoemaker Mary Teresa	Director	Nov 25	Buy	0.27	37,735	10,000	37,735	Nov 30 05:14 PM
Guerin Mark Patrick	Chief Financial Officer	Nov 25	Buy	0.26	16,755	4,356	125,599	Nov 30 05:11 PM
OLER ABRAHAM N.	SVP Corp Dev & Gen Counsel	Nov 25	Buy	0.26	20,000	5,120	110,000	Nov 30 05:09 PM
Fruchtman Steven M	President, Chief Executive Off	Nov 25	Buy	0.26	40,000	10,360	216,226	Nov 30 05:08 PM
MARINO JAMES J	Director	Nov 24	Buy	0.26	38,774	10,004	205,716	Nov 27 01:34 PM
Reddy E Premkumar	Director	Aug 27	Sale	0.27	527,863	143,948	16,683	Aug 31 04:49 PM
Hoffman Michael B	Director	Aug 27	Sale	0.27	182,492	49,620	21,919	Aug 31 04:42 PM
Hoffman Michael B	Director	Aug 27	Sale	0.27	1,876	510	0	Aug 31 04:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience